BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1003870)

  • 1. [Alterations of bile acid metabolism during treatment with chenodeoxycholic acid. Studies of the role of the appearance of ursodeoxycholic acid in the dissolution of gallstones (author's transl)].
    Fromm H; Erbler HC; Eschler A; Schmidt FW
    Klin Wochenschr; 1976 Dec; 54(23):1125-31. PubMed ID: 1003870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone.
    Podda M; Zuin M; Battezzati PM; Ghezzi C; de Fazio C; Dioguardi ML
    Gastroenterology; 1989 Jan; 96(1):222-9. PubMed ID: 2642440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
    Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
    Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool, and serum lipids.
    Roehrkasse R; Fromm H; Malavolti M; Tunuguntla AK; Ceryak S
    Dig Dis Sci; 1986 Oct; 31(10):1032-40. PubMed ID: 3757719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of varying doses of chenodeoxycholic acid on bile lipid and biliary bile acid composition in gallstone patients: a dose-response study.
    Thistle JL; Hofmann AF; Yu PY; Ott B
    Am J Dig Dis; 1977 Jan; 22(1):1-6. PubMed ID: 835542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution of cholesterol gallstones by bile acids in hamsters.
    Sue SO; Bonorris GG; Marks JW; Vimadalal S; Schoenfield LJ
    Am J Med Sci; 1982; 284(1):18-23. PubMed ID: 7091181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7-Methyl bile acids: effects of chenodeoxycholic acid, cholic acid, and their 7 beta-methyl analogues on the formation of cholesterol gallstones in the prairie dog.
    Matoba N; Cohen BI; Mosbach EH; Stenger RJ; Kuroki S; Une M; McSherry CK
    Gastroenterology; 1989 Jan; 96(1):178-85. PubMed ID: 2909419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry identification of biliary bile acids in bile from patients with gallstones before and during treatment with chenodeoxycholic acid. An ancillary study of the National Cooperative Gallstone Study.
    Stellaard F; Klein PD; Hofmann AF; Lachin JM
    J Lab Clin Med; 1985 Apr; 105(4):504-13. PubMed ID: 3981060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of primary bile acid ingestion on bile acid metabolism and biliary lipid secretion in gallstone patients.
    LaRusso NF; Hoffman NE; Hofmann AF; Northfield TC; Thistle JL
    Gastroenterology; 1975 Dec; 69(6):1301-14. PubMed ID: 1193329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased formation of ursodeoxycholic acid in patients treated with chenodeoxycholic acid.
    Salen G; Tint GS; Eliav B; Deering N; Mosbach EH
    J Clin Invest; 1974 Feb; 53(2):612-21. PubMed ID: 11344576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chenotherapy for gallstone dissolution. II. Induced changes in bile composition and gallstone response.
    Hofmann AF; Thistle JL; Klein PD; Szczepanik PA; Yu PY
    JAMA; 1978 Mar; 239(12):1138-44. PubMed ID: 628065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acids in bile during long-term chenodeoxycholic acid treatment.
    Bremmelgaard A; Pedersen L
    Scand J Gastroenterol; 1976; 11(2):161-5. PubMed ID: 1265436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
    Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
    J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallstone dissolution by chenodeoxycholic acid and phenobarbital.
    Marks JW; Sherman JH; Bonorris GG; Chung A; Coyne MJ; Schoenfield LJ
    Am J Gastroenterol; 1978 Feb; 69(2):160-5. PubMed ID: 352139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallbladder function during gallstone dissolution. Effect of bile acid therapy in patients with gallstones.
    Sylwestrowicz TA; Shaffer EA
    Gastroenterology; 1988 Sep; 95(3):740-8. PubMed ID: 3396819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesophase formation during cholesterol gallstone dissolution in human bile: effect of bile acid composition.
    Su CC; Higuchi WI; Gilmore IT; Danzinger RG; Hofmann AF
    J Pharm Sci; 1984 Aug; 73(8):1160-1. PubMed ID: 6491925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of prosthetic gallstones on total bile acid pool size in dogs.
    Thurston OG; McDougall RM; Walker K
    Surg Gynecol Obstet; 1978 Jun; 146(6):911-3. PubMed ID: 653567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.